Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.32B |
| 2 |
Apple
AAPL
|
+$484M |
| 3 |
Johnson & Johnson
JNJ
|
+$229M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$201M |
| 5 |
Intel
INTC
|
+$190M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$726M |
| 2 |
BCE
BCE
|
+$374M |
| 3 |
KKR & Co
KKR
|
+$239M |
| 4 |
Canadian Imperial Bank of Commerce
CM
|
+$202M |
| 5 |
Home Depot
HD
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.44% |
| 2 | Miscellaneous | 16.43% |
| 3 | Technology | 10.23% |
| 4 | Energy | 9.1% |
| 5 | Communication Services | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2876
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.6B
| $160K | ﹤0.01% |
5,861
-86,249
| -94% | -$2.36M |
2013 Q2
20 quarters
|
|
|
MRT
2877
DELISTED
MedEquities Realty Trust, Inc.
MRT
| $160K | ﹤0.01% |
14,483
+203
| +1% | +$2.1K |
2018 Q1
1 quarter
|
|
2878
Aclaris Therapeutics
ACRS
$657M
| $159K | ﹤0.01% |
7,944
+152
| +2% | +$2.81K |
2016 Q4
6 quarters
|
|
2879
Amplify Energy
AMPY
$178M
| $159K | ﹤0.01% |
11,761
-5,267
| -31% | -$71.3K |
2017 Q3
3 quarters
|
|
|
BCPC
2880
Balchem Corp
BCPC
$5.31B
| $159K | ﹤0.01% |
1,634
+228
| +16% | +$21.2K |
2013 Q2
20 quarters
|
|
2881
nLIGHT
LASR
$2.33B
| $158K | ﹤0.01% |
+4,760
| New | +$160K |
2018 Q2
0 quarters
|
|
2882
Collegium Pharmaceutical
COLL
$722M
| $157K | ﹤0.01% |
6,608
+254
| +4% | +$6.25K |
2016 Q1
9 quarters
|
|
2883
HNI Corp
HNI
$3.39B
| $157K | ﹤0.01% |
4,238
+585
| +16% | +$21.4K |
2013 Q2
20 quarters
|
|
2884
RBB Bancorp
RBB
$443M
| $157K | ﹤0.01% |
+4,895
| New | +$144K |
2018 Q2
0 quarters
|
|
|
MARK
2885
DELISTED
Remark Holdings, Inc.
MARK
| $157K | ﹤0.01% |
4,019
+1,119
| +39% | +$61.2K |
2017 Q4
2 quarters
|
|
2886
Coherent
COHR
$65.6B
| $156K | ﹤0.01% |
3,599
+439
| +14% | +$19.4K |
2013 Q2
20 quarters
|
|
2887
iShares Dow Jones US ETF
IYY
$3.06B
| $156K | ﹤0.01% |
2,280
+174
| +8% | +$11.8K |
2013 Q2
20 quarters
|
|
2888
Kiniksa Pharmaceuticals
KNSA
$5.89B
| $156K | ﹤0.01% |
+9,000
| New | +$163K |
2018 Q2
0 quarters
|
|
|
ALBO
2889
DELISTED
Albireo Pharma Inc
ALBO
| $156K | ﹤0.01% |
4,395
+65
| +2% | +$2.1K |
2018 Q1
1 quarter
|
|
2890
Rocky Brands
RCKY
$343M
| $155K | ﹤0.01% |
+5,195
| New | +$135K |
2018 Q2
0 quarters
|
|
2891
Universal Logistics Holdings
ULH
$483M
| $155K | ﹤0.01% |
+5,885
| New | +$140K |
2018 Q2
0 quarters
|
|
|
HYB
2892
DELISTED
New America High Income Fund, Inc.
HYB
| $155K | ﹤0.01% |
18,005
-847
| -4% | -$7.35K |
2017 Q3
3 quarters
|
|
|
SBOW
2893
DELISTED
SilverBow Resources, Inc.
SBOW
| $155K | ﹤0.01% |
5,394
+50
| +0.9% | +$1.47K |
2017 Q4
2 quarters
|
|
|
NVTA
2894
DELISTED
Invitae Corporation
NVTA
| $155K | ﹤0.01% |
+21,110
| New | +$140K |
2018 Q2
0 quarters
|
|
|
DBD
2895
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
| $155K | ﹤0.01% |
13,000
+3,000
| +30% | +$40.1K |
2018 Q1
1 quarter
|
|
|
AAV
2896
PUT
DELISTED
Advantage Oil & Gas Ltd
AAV
| $155K | ﹤0.01% |
50,000
+26,000
| +108% | +$80.5K |
2017 Q4
2 quarters
|
|
|
BPMC
2897
DELISTED
Blueprint Medicines
BPMC
| $154K | ﹤0.01% |
2,432
+748
| +44% | +$59.5K |
2016 Q4
6 quarters
|
|
2898
The Bancorp
TBBK
$1.98B
| $154K | ﹤0.01% |
14,784
+11,983
| +428% | +$132K |
2015 Q1
13 quarters
|
|
|
OBE
2899
Obsidian Energy
OBE
$681M
| $153K | ﹤0.01% |
19,431
-2,327
| -11% | -$18.3K |
2017 Q3
3 quarters
|
|
|
PTX
2900
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $153K | ﹤0.01% |
63,000
+60,000
| +2,000% | +$147K |
2018 Q1
1 quarter
|
|
Similar funds
Bank of Montreal's Q2 2018 Portfolio in Review
As of Q2 2018, Bank of Montreal held 5,040 positions worth $121B, up 8.1% from $112B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Bank of Montreal's Q2 2018 filing shows 828 new, 1,968 increased, 1,537 reduced and 277 closed positions. Its largest new stake was iShares Global Timber & Forestry ETF: 373,810 shares worth $29.2M. The largest sale was iShares Core S&P 500 ETF, an estimated $726M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 27% a quarter earlier, followed by Miscellaneous and Technology.
- Bank of Montreal's largest Q2 2018 buy was iShares Global Timber & Forestry ETF: 373,810 shares worth $29.2M.
- Bank of Montreal added most to Amazon in Q2 2018, an estimated $1.32B increase.
- Bank of Montreal's biggest Q2 2018 reduction was iShares Core S&P 500 ETF, cutting an estimated $726M.
- Bank of Montreal fully exited Monsanto Co in Q2 2018, selling an estimated $129M.
- Bank of Montreal's ten largest holdings make up 23% of its $121B portfolio in Q2 2018.
- Bank of Montreal opened 828 new positions and closed 277 in Q2 2018.
- Bank of Montreal's portfolio value rose 8.1% quarter-over-quarter to $121B.
Based on Bank of Montreal's 13F filing for Q2 2018, filed 16 Jul 2018.